Fibroblastic Stromal Cells Express Receptor Activator of NF‐κB Ligand and Support Osteoclast Differentiation

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2000-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1359/jbmr.2000.15.8.1459PMID 10934644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atypical fibroxanthoma with osteoclast-like multinucleated giant cells.

  2000cited by this paper
• Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

  1999cited by this paper
• RANK is essential for osteoclast and lymph node development.

  1999cited by this paper
• Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion.

  1999cited by this paper
• Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

  1999cited by this paper
• Activated T lymphocytes support osteoclast formation in vitro.

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells.

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• Human tumour‐associated macrophages differentiate into osteoclastic bone‐resorbing cells

  1998cited by this paper
• Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids.

  1998cited by this paper
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• Atypical fibroxanthoma with osteoclast-like multinucleated giant cells.

  1997cited by this paper
• Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype.

  1997cited by this paper
• CELLS OF THE MONONUCLEAR PHAGOCYTE SERIES DIFFERENTIATE INTO OSTEOCLASTIC LACUNAR BONE RESORBING CELLS

  1996cited by this paper
• Effects of continuous calcitonin treatment on osteoclast‐like cell development and calcitonin receptor expression in mouse bone marrow cultures

  1996cited by this paper
• Bone cells required for osteoclastic resorption but not for osteoclastic differentiation.

  1996cited by this paper
• Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

  1995cited by this paper
• Cellular and hormonal mechanisms associated with malignant bone resorption.

  1994cited by this paper
• Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells.

  1994cited by this paper
• Characterization of intraocular tumors arising in transgenic mice.

  1994cited by this paper
• Polymethylmethacrylate-induced inflammatory macrophages resorb bone.

  1992cited by this paper
• Modulation of osteoclast differentiation [published erratum appears in Endocr Rev 1992 May;13(2):191]

  1992cited by this paper
• Preparation and characterization of a mouse osteoclast‐like multinucleated cell population

  1992cited by this paper
• Modulation of osteoclast differentiation.

  1992cited by this paper
• Bone resorption by macrophage polykaryons of a pilar tumor of scalp

  1992cited by this paper
• Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function.

  1991cited by this paper
• Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath.

  1991cited by this paper
• The origin and nature of stromal osteoclast-like multinucleated giant cells in breast carcinoma: implications for tumour osteolysis and macrophage biology.

  1989cited by this paper
• Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

  1986cited by this paper
• Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact.

  1985cited by this paper
• Resorption of bone by isolated rabbit osteoclasts.

  1984cited by this paper

• Porphyran Inhibits Osteoclast Formation Based on NF-κB Signaling Pathways and Accelerates Alveolar Bone Healing in Ovariectomized Mice.

  2025cites this paper
• Signaling Pathways in Root Resorption: Linking Inflammation, Odontoclastogenesis, and Tissue Remodeling.

  2025cites this paper
• Immunosuppressive tumor microenvironment and advance in immunotherapy in melanoma bone metastasis

  2025cites this paper
• Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development

  2024cites this paper
• Roles of IL-11 in the regulation of bone metabolism

  2024cites this paper
• Inhibition of KIF11 ameliorates osteoclastogenesis via regulating mTORC1-mediated NF-κB signaling.

  2023cites this paper
• Roles of osteoclasts in alveolar bone remodeling

  2022cites this paper
• Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation

  2022cites this paper
• Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment

  2022cites this paper
• Myeloproliferative Disorders and its Effect on Bone Homeostasis: The Role of Megakaryocytes.

  2021cites this paper
• The hidden secrets of soluble RANKL in bone biology.

  2021cites this paper
• The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling

  2019influential citation
• Impact of Periprosthetic Fibroblast-Like Cells on Osteoclastogenesis in Co-Culture with Peripheral Blood Mononuclear Cells Varies Depending on Culture System

  2019cites this paper
• MicroRNA‐1225 activates Keap1‐Nrf2‐HO‐1 signalling to inhibit TNFα‐induced osteoclastogenesis by mediating ROS generation

  2019cites this paper
• Omnipresence of inflammasome activities in inflammatory bone diseases

  2019cites this paper
• Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis

  2019cites this paper
• TRPV2-induced Ca2+-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma

  2018cites this paper
• Local administration of calcitonin inhibits alveolar bone loss in an experimental periodontitis in rats.

  2018cites this paper
• Sirtuin 1 inhibits TNF-α-mediated osteoclastogenesis of bone marrow-derived macrophages through both ROS generation and TRPV1 activation

  2018cites this paper
• Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review

  2017cites this paper
• Association of salivary RANKL and osteoprotegerin levels with periodontal health

  2017cites this paper
• Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis

  2017cites this paper
• Wear and Osteolysis of Polyethylene Bearings

  2017cites this paper
• The bone-implant interface biology and potential targets for pharmacological interventions

  2017cites this paper
• Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation

  2017cites this paper
• Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS

  2017cites this paper
• Ameloblastin and enamelin prevent osteoclast formation by suppressing RANKL expression via MAPK signaling pathway.

  2017cites this paper
• Targeted delivery of morin, a dietary bioflavanol encapsulated mannosylated liposomes to the macrophages of adjuvant‐induced arthritis rats inhibits inflammatory immune response and osteoclastogenesis

  2017cites this paper
• Correlation of Vitamin D status and orthodontic-induced external apical root resorption

  2017cites this paper
• Vitamin D Status and Supplementation in the Critically Ill

  2016cites this paper
• Association Of Salivary Receptor Activator Of Nuclear Factor Ligand And Osteoprotegerin Levels With Periodontal Clinical Status

  2016cites this paper
• Pitavastatin attenuates monocyte activation in response to orthopedic implant-derived wear particles by suppressing the NF-κB signaling pathway.

  2015cites this paper
• Osteoimmunology in orthodontic tooth movement.

  2015cites this paper
• The role of macrophages in the biological reaction to wear debris from joint replacements

  2015cites this paper
• Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation

  2015cites this paper
• Destruction induced Bone − Lipopolysaccharide Porphyromonas endodontalis Calcium Hydroxide Suppresses

  2014cites this paper
• In vitro investigation of the roles of the proinflammatory cytokines tumor necrosis factor-α and interleukin-1 in murine osteoclastogenesis.

  2014cites this paper
• Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.

  2014cites this paper
• Calcium Hydroxide Suppresses Porphyromonas endodontalis Lipopolysaccharide–induced Bone Destruction

  2014cites this paper
• Fibrodysplasia Ossificans Progressiva-related Activated Activin-like Kinase Signaling Enhances Osteoclast Formation during Heterotopic Ossification in Muscle Tissues*

  2014cites this paper
• The TNF Superfamily

  2014cites this paper
• Reflections on Development of Concepts of Intercellular Communication in Bone

  2013cites this paper
• Extracellular Matrix Degradation and Tissue Remodeling in Periprosthetic Loosening and Osteolysis: Focus on Matrix Metalloproteinases, Their Endogenous Tissue Inhibitors, and the Proteasome

  2013cites this paper
• Cells of the Immune System Orchestrate Changes in Bone Cell Function

  2013cites this paper
• Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health

  2013cites this paper
• Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts

  2013cites this paper
• Historically significant events in the discovery of RANK/RANKL/OPG.

  2013cites this paper
• The role of osteoblasts in peri-prosthetic osteolysis.

  2013cites this paper
• Immune cells and bone: coupling goes both ways

  2013cites this paper
• Immunohistochemical expression of biglycan and decorin in the pulp tissue of human primary teeth during resorption.

  2013cites this paper
• The effect of local application of melatonin gel on the healing of periodontal osseous defects in experimentally induced diabetes in rabbits

  2013cites this paper
• Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.

  2013cites this paper
• Gingival crevicular fluid and serum levels of APRIL, BAFF and TNF-alpha in rheumatoid arthritis and osteoporosis patients with periodontal disease.

  2013cites this paper
• “ Expression of Bone Resorption Markers in Gingival Crevicular Fluid of Rheumatoid Arthritis Patients with and without Periodontitis

  2012cites this paper
• Osteoclast progenitors from cats with and without tooth resorption respond differently to 1,25-dihydroxyvitamin D and interleukin-6.

  2012cites this paper
• Toll-like receptors and macrophage polarization in the loosening of total hip replacements

  2012cites this paper
• Early growth response 2 negatively modulates osteoclast differentiation through upregulation of Id helix-loop-helix proteins.

  2012cites this paper
• Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors.

  2012cites this paper
• Interactions of porphyromonas gingivalis with bone marrow cells: implications on mediators of bone resorption

  2012cites this paper
• Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis.

  2012cites this paper
• Oral health and bisphopshonate-associated jaw osteonecrosis

  2012cites this paper
• Current concepts in osteolysis.

  2012cites this paper
• Osteoblast‐targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy‐induced bone loss in female mice

  2011cites this paper
• Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis.

  2011cites this paper
• Paracrine‐mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts

  2011cites this paper
• Role of polyethylene particles in peri-prosthetic osteolysis: A review.

  2011cites this paper
• C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study.

  2011cites this paper
• Elevated cytokine production restores bone resorption by human Btk‐deficient osteoclasts

  2011cites this paper
• Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.

  2010cites this paper
• Osteolysis in total joint replacement – are patient factors important?

  2010cites this paper
• Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors.

  2010cites this paper
• IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.

  2010cites this paper
• Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients.

  2010cites this paper
• Receptor Activator of NF-κB (RANK) Cytoplasmic IVVY535–538 Motif Plays an Essential Role in Tumor Necrosis Factor-α (TNF)-mediated Osteoclastogenesis*

  2010cites this paper
• THIAZOLIDINEDIONES INHIBIT TNF-&agr;-MEDIATED OSTEOCLAST DIFFERENTIATION OF RAW264.7 MACROPHAGES AND MOUSE BONE MARROW CELLS THROUGH DOWNREGULATION OF NFATc1

  2010cites this paper
• Increased vitamin D-driven signalling and expression of the vitamin D receptor, MSX2, and RANKL in tooth resorption in cats.

  2010cites this paper
• Commitment to the Osteoblast Lineage Is Not Required for RANKL Gene Expression*

  2009cites this paper
• From Bone To Heart Corresponding

  2009cites this paper
• Pathogenic bone loss in rheumatoid arthritis: mechanisms and therapeutic approaches

  2009cites this paper
• Platelet‐derived growth factor stimulates osteoprotegerin production in osteoblastic cells

  2009cites this paper
• Expression and regulation of cathepsin K in skin fibroblasts

  2009cites this paper
• Lipoxin A4 Metabolites/Analogues from Two Commercial Sources have No Effects on TNF‐α‐mediated Priming or Activation through the Neutrophil Formyl Peptide Receptors

  2009cites this paper
• Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing

  2009cites this paper
• Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment.

  2009cites this paper
• The effect of five osteotropic factors on osteoprotegerin mRNA expression in gingival fibroblasts

  2008cites this paper
• Osteoprotegerin levels in peri-implant crevicular fluid.

  2008cites this paper
• Targeting p38 MAPK for the treatment of inflammatory arthritis

  2008cites this paper
• Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets.

  2008cites this paper
• Reduced COX-2 Expression in Aged Mice Is Associated With Impaired Fracture Healing

  2008cites this paper
• Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

  2008cites this paper
• Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients.

  2008cites this paper
• Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease.

  2007cites this paper
• Alcohol-induced disruption of endocrine signaling.

  2007cites this paper
• RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer

  2007cites this paper
• Development of an ex vivo cellular model of rheumatoid arthritis: critical role of CD14-positive monocyte/macrophages in the development of pannus tissue.

  2007cites this paper
• The cellular and molecular biology of periprosthetic osteolysis.

  2007cites this paper
• Osteoprotegerin Reduces the Serum Level of Receptor Activator of NF-κB Ligand Derived from Osteoblasts1

  2007cites this paper
• Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.

  2006cites this paper
• Pathophysiology and treatment of pain in joint disease.

  2006cites this paper
• Estradiol Protects against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-κB Ligand in Osteoblasts

  2006cites this paper